CDK4 and hematopoietic and lymphoid cell neoplasm: The most potent chimera (Figure 7B) inhibited the proliferation of several hematopoietic cancer cells (DC50 values for CDK6 and CDK4 were 2.1 nM and more than 150–180 nM, respectively).